Spironolactone and Aczone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Spironolactone (spironolactone) and Aczone (dapsone). Common drug interactions include therapeutic response unexpected among females.
The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Aczone. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.
What is Spironolactone?
Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.
What is Aczone?
Aczone has active ingredients of dapsone. It is often used in acne. eHealthMe is studying from 1,152 Aczone users. Check the latest studies of Aczone.
66 people who take Spironolactone and Aczone together, and have interactions are studied.

What are the common drug interactions of Spironolactone and Aczone, by gender? *:
female:
- Therapeutic response unexpected
- Drug ineffective
- Muscle spasms (muscle contraction)
- Nausea (feeling of having an urge to vomit)
- Pain
- Burning sensation
- Cervical radiculopathy (disturbance of nerve function that causes pain in the upper body)
- Depression
- Diarrhoea
- Dysuria (painful or difficult urination)
male:
n/a
What are the common drug interactions of Spironolactone and Aczone, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
- Cough
- Nausea (feeling of having an urge to vomit)
- Throat irritation
- Vomiting
20-29:
- Weight increased
- Decreased appetite
- Irritable bowel syndrome
- Mixed connective tissue disease (an autoimmune disease, in which the body's defence system attacks itself)
- Therapeutic response unexpected
- Weight decreased
- Cyst (a closed sac)
- Hypoaesthesia (reduced sense of touch or sensation)
- Pain
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
30-39:
- Drug ineffective
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Gait disturbance
- Muscular weakness (muscle weakness)
- Acute respiratory distress syndrome
- Adverse drug reaction
- Anal fistula
- Coma (state of unconsciousness lasting more than six hours)
- Device dislocation
- Drug specific antibody present
40-49:
- Therapeutic response unexpected
- Attention deficit/hyperactivity disorder
- Feeling hot
- Flushing (the warm, red condition of human skin)
- Skin burning sensation
- Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Bruxism (habitual grinding of the teeth, typically during sleep)
- Dyskinesia (abnormality or impairment of voluntary movement)
- Dyspnoea (difficult or laboured respiration)
50-59:
- Chronic kidney disease
- Renal injury (kidney injury)
60+:
n/a
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 36 people, 54.55%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 30 people, 45.45%
- Stress And Anxiety: 7 people, 10.61%
- Depression: 7 people, 10.61%
- Irritable Bowel Syndrome: 6 people, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.09%
- Acne Cystic (skin problems that cause pimples): 6 people, 9.09%
- Migraine (headache): 4 people, 6.06%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 6.06%
- Diabetes: 4 people, 6.06%
* Approximation only. Some reports may have incomplete information.
Do you take Spironolactone and Aczone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Spironolactone (122,947 reports)
- Aczone (1,152 reports)
Browse all drug interactions of Spironolactone and Aczone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Spironolactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aczone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Spironolactone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aczone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on spironolactone and dapsone (the active ingredients of Spironolactone and Aczone, respectively), and Spironolactone and Aczone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zoledronic Acid and Timolol - 4 seconds ago
- Zofran and Soma drug interactions for women aged 40-49 - 7 seconds ago
- Drug interactions of Lamotrigine and Imitrex - 10 seconds ago
- Drug interactions of Moviprep and Nexium 24Hr - 16 seconds ago
- Aggression in Abilify, how severe and when it was recovered? - 16 seconds ago
- Acute Lymphocytic Leukemia (All) and Reversible Posterior Leukoencephalopathy Syndrome - 22 seconds ago
- Could Robaxin cause Chills? - 51 seconds ago
- Could Doxycycline Hyclate cause Paronychia? - a minute ago
- Haemoglobin Decreased and drugs of ingredients of sufentanil citrate - a minute ago
- Drug interactions of Sudafed and Contac - a minute ago